<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">JCT</journal-id><journal-title-group><journal-title>Journal of Cancer Therapy</journal-title></journal-title-group><issn pub-type="epub">2151-1934</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/jct.2020.115027</article-id><article-id pub-id-type="publisher-id">JCT-100306</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Sexual and Urinary Disorders after Treatment of Rectal Cancer by Radiotherapy and Surgery at the Dantec University Hospital of Dakar
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mouhamadou</surname><given-names>Bachir Ba</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Papa</surname><given-names>Macoumba Gaye</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Karim</surname><given-names>Konate</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ahmadou</surname><given-names>Dem</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>Joliot Curie Institute, Dakar, Senegal</addr-line></aff><aff id="aff1"><addr-line>Radiotherapy Department, Dalaljamm Hospital, Dakar, Senegal</addr-line></aff><pub-date pub-type="epub"><day>27</day><month>04</month><year>2020</year></pub-date><volume>11</volume><issue>05</issue><fpage>332</fpage><lpage>338</lpage><history><date date-type="received"><day>30,</day>	<month>September</month>	<year>2018</year></date><date date-type="rev-recd"><day>16,</day>	<month>May</month>	<year>2020</year>	</date><date date-type="accepted"><day>19,</day>	<month>May</month>	<year>2020</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  We performed a descriptive retrospective study of sexual and urinary disorders after treatment of rectal cancer by radiotherapy and/or surgery at the Dantec University Hospital in Dakar from 2008 to 2015. The objective of the study was to evaluate these sexual and urinary complications and the factors influencing it. We have collected 50 patients. The average age of is 55.7 years with a sex ratio of 0.78. The dominant clinical signs are rectorrhagia (66.0%). Endoscopy (94.0% of patients) showed an ulcerative-budding appearance in 84.0% of cases. The preferred location was the lower rectum 66.0%). The predominant histologic type is adenocarcinoma lieberkunien (82.0%). Computed tomography is performed in 78% of cases and MRI in 30%. Stage III accounts for 70.0% of cases. Thirty-two patients (64.0%) were treated with conventional 2-beam 2D radiation therapy with or without chemotherapy. The total dose of 46 Gy in 23 sessions was the most used, found in 22 patients; 30 Gy in 10 sessions in 9 cases. And 16 Gy in 10 sessions, found in 1 case. Surgery performed was abdominoperineal amputation (58.0%) and conservative surgery (42.0%). We note a complete response in 28.0% of patients; 8.0%, an increase of 16.0% and a stabilization of 4.0%. The sexual disorders are more important after radiotherapy compared to non-irradiated patients: 31.3% vs 5.6% (p = 0.035). We observe respectively that 2%, 6% and 8% of our patients had urinary disorders in the form of acute retention, urinary incontinence, and urinary burning. Patient follow-up time was between 0 and 42.83 months with an estimated average of 34.9 &#177; 3
  .
  37. The evolution is marked at 6 months by a persistence of sexual disorders in 63.8% of cases and urinary dysfunction in 4% of cases.
 
</p></abstract><kwd-group><kwd>Sexual</kwd><kwd> Urinary Disorders After</kwd><kwd> Rectal Cancers</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Surgery is the cornerstone of rectal cancer treatment. It consists of total removal of the mesorectum. Neoadjuvant radiotherapy is indicated for locally advanced operable tumors [<xref ref-type="bibr" rid="scirp.100306-ref1">1</xref>].</p><p>The locoregional treatment constituted by the association of radiotherapy and surgery can lead to sexual and urinary disorders. We are evaluating this type of complication in the management of rectal cancers at CHU, The Dantec of Dakar.</p></sec><sec id="s2"><title>2. Patients and Methods</title><sec id="s2_1"><title>2.1. Study Framework</title><p>This study was conducted at the Joliot Curie Institute of Dakar, which includes a radiotherapy unit, a surgery unit and a chemotherapy unit.</p></sec><sec id="s2_2"><title>2.2. Type of Study</title><p>It is a descriptive retrospective study of 50 patients treated by surgery and/or radiotherapy for rectal cancer from January 2008 to December 2015.</p></sec><sec id="s2_3"><title>2.3. Objective of the Study</title><p>The objective is to assess sexual complications and the influencing factors.</p></sec><sec id="s2_4"><title>2.4. Selection Criteria</title><p>We included during this period all consecutive patients with histologically confirmed rectal cancer.</p></sec><sec id="s2_5"><title>2.5. Data Collection and Analysis</title><p>We used the following documents: patient medical records, hospitalization, operating room and histopathology laboratory records.</p><p>The data collected were entered into Excel and processed using the SPSS 21 software.</p></sec></sec><sec id="s3"><title>3. Results</title><p>The 50 patients, 22 men and 28 women (Sex Ratio: 0.78), are 55.7 years old on average. The dominant clinical signs are rectorragies, found in 66.0% of cases. Endoscopy is performed in 94.0% of cases, showing an ulcer-budding appearance in 84.0% of cases. The tumor is localized to the lower rectum in 33 patients (66.0%). The predominant histologic type is lieberkunian adenocarcinoma (82.0%). Stage III is the most represented (70.0%).</p><p>On the therapeutic level, thirty-two patients (64.0%) benefited from treatment by conventional 2D radiotherapy with 2 beams associated or not with chemotherapy: Eight (08) by exclusive radiotherapy (RTE) preoperative, Twenty (20) by concomitant radiochemotherapy (RCT) preoperative, one (01) RTE preoperative and chemotherapy (CT) postoperative, two (02) by RTE postoperative and one (1) RCT postoperative</p><p>The total dose of 46 Gy (23 fractions of 5 days per week) is found in 22 patients; 30 Gy in 10 sessions in 9 cases and 16 Gy in 10 fractions in 1 case.</p><p>Conventional splits had an average spread of 30.14 days and hypofractions of 13.24 days. After irradiation, we note a complete response in 28.0% of patients; partial response in 8.0%, progression in 16.0% of patients and stabilization in 4.0% of patients.</p><p>The surgery performed is abdominal-perineal amputation in 58.0% of cases and resection with sphincterial conservation in 42.0% (anterior resection in 17 patients and total proctectomy in 4 patients). The surgical technique influenced the sexual functional result (<xref ref-type="table" rid="table1">Table 1</xref>).</p><p>Sexual disorders are more important after radiotherapy compared to non-irradiated patients: 31.3% vs 5.6% (p = 0.035) (<xref ref-type="table" rid="table2">Table 2</xref>).</p><p>At 6 months, the evolution is marked by persistent sexual problems in 63.8% of cases and urinary dysfunction in 4% of cases.</p><p>Patient follow-up ranged from 0 to 42.83 months with an estimated mean of 34.9 &#177; 3.37 (95% CI = [28.270 - 41.465]).</p><p>From 3 months the survival, which was 0.978 &#177; 0.022, decreases to 0.878 &#177; 0.052 at the 6<sup>th</sup> month and stabilizes until the 26th month. It is 0.658 &#177; 0.194 and was obtained from the 28<sup>th</sup> month (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p></sec><sec id="s4"><title>4. Discussion</title><p>The average age of our patients is 55.7 years. It ranges from 65 to 75 years in Western literature [<xref ref-type="bibr" rid="scirp.100306-ref2">2</xref>]. This young age is one more argument for studying sexual disorders after treatment.</p><p>We can improve the pre-therapeutic assessment of our patients. Computed tomography is performed for 78% of them. It has a diagnostic accuracy of 55% to 72% for tumor and 25% to 75% for adenopathies.</p><p>Magnetic resonance imaging has better resolution for mesorectum. We have done it for 30% of our patients. According to Beets-Tan et al., an IRM distance of 5 mm between the tumor and fascia led to a resection margin of 1 mm on</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Sexual disorders by type of anastomosis and stom</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Sexual disorders</th><th align="center" valign="middle" >High colorectal anastomosis (7)</th><th align="center" valign="middle" >Low colorectal anastomosis (10)</th><th align="center" valign="middle" >Colo anale anastomosis (4)</th><th align="center" valign="middle" >Final colostomy (29)</th></tr></thead><tr><td align="center" valign="middle" >Ejaculation disorder</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >10</td></tr><tr><td align="center" valign="middle" >Erectile dysfunction</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >10</td></tr></tbody></table></table-wrap><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Sexual disorders by radiation therapy</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Sexual disorders</th><th align="center" valign="middle" >RTE (32)</th><th align="center" valign="middle" >Without RTE (18)</th><th align="center" valign="middle" >p</th><th align="center" valign="middle" >OR</th><th align="center" valign="middle" >IC to 95%</th></tr></thead><tr><td align="center" valign="middle" >Ejaculation disorder</td><td align="center" valign="middle" >10 (31.3%)</td><td align="center" valign="middle" >1 (5.6%)</td><td align="center" valign="middle" >0.035</td><td align="center" valign="middle" >7.727</td><td align="center" valign="middle" >[0.899 - 66.394]</td></tr><tr><td align="center" valign="middle" >Erectile dysfunction</td><td align="center" valign="middle" >10 (31.3%)</td><td align="center" valign="middle" >1 (5.6%)</td><td align="center" valign="middle" >0.035</td><td align="center" valign="middle" >7.727</td><td align="center" valign="middle" >[0.899 - 66.394]</td></tr></tbody></table></table-wrap><p>histological examination and better predicted resection margins [<xref ref-type="bibr" rid="scirp.100306-ref3">3</xref>].</p><p>The German Rectal Cancer Group compared a pre-operative or adjuvant RCT approach. The first approach offered a benefit in terms of local control (6% versus 13%) [<xref ref-type="bibr" rid="scirp.100306-ref4">4</xref>]. We have 20 cases of pre-operative RCT, while only one case has had post-operative RCT.</p><p>Abdominal amputation is performed in 58% of cases and sphincter conservation surgery in 42%. The sphincterial conservation rate of different foreign series is given in <xref ref-type="table" rid="table3">Table 3</xref>.</p><sec id="s4_1"><title>4.1. Sexual Disorders</title><p>Very few studies have specifically studied sexual disorders in women. Age is associated with decreased sexual activity in both the male and female population. Post-operative sexual activity is 86% among those under 60 years and 46% after 60 years [<xref ref-type="bibr" rid="scirp.100306-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.100306-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.100306-ref7">7</xref>]. We find a rate of sexual disorders in men lower than that found in foreign series (<xref ref-type="table" rid="table4">Table 4</xref>).</p><p>According to Lange, the risk of nerve damage during dissection in the narrow male pelvis is higher than in women. However, the instruments used to assess sexual disorders are different between men and women, so comparison between the two sexes is difficult [<xref ref-type="bibr" rid="scirp.100306-ref8">8</xref>].</p><p>The rate of sexual impotence after rectal surgery varies from 5% to 92% [<xref ref-type="bibr" rid="scirp.100306-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.100306-ref10">10</xref>]. We found a significant difference depending on the type of surgery. Thus, 66% of our patients had functional sexual disorders after prior resection of the rectum. They were more important after abdominal-perineal amputation. Our results are consistent with the data in the literature [<xref ref-type="bibr" rid="scirp.100306-ref11">11</xref>]. However, the preservation of the autonomic nervous system is not specified in our patients’ operating reports.</p><p>Like Bonnel et al., Heriot et al., we note a deleterious effect of radiotherapy on sexual function [<xref ref-type="bibr" rid="scirp.100306-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.100306-ref12">12</xref>]. A Dutch study including 990 patients reported a decline in sexual activity in both sexes after radiotherapy [<xref ref-type="bibr" rid="scirp.100306-ref13">13</xref>].</p><p>The efficacy of sildenafil on these disorders has been described. Erectile function is improved in 80% of patients compared to 17% with placebo [<xref ref-type="bibr" rid="scirp.100306-ref14">14</xref>].</p><p>Finally, the insertion of a penile prosthesis is effective but irreversible and</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Sphincter conservation rates in our series and in the literature [<xref ref-type="bibr" rid="scirp.100306-ref23">23</xref>]</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Our series</th><th align="center" valign="middle" >Mohuiddin et al. (121)</th><th align="center" valign="middle" >Rouanet et al. (143)</th><th align="center" valign="middle" >Crane et al. (34)</th><th align="center" valign="middle" >Rengan et al. (138)</th><th align="center" valign="middle" >Kim et al. (91)</th></tr></thead><tr><td align="center" valign="middle" >42%</td><td align="center" valign="middle" >90%</td><td align="center" valign="middle" >70%</td><td align="center" valign="middle" >50%</td><td align="center" valign="middle" >77%</td><td align="center" valign="middle" >35%</td></tr></tbody></table></table-wrap><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Sexual disorders in our series and in the literature [<xref ref-type="bibr" rid="scirp.100306-ref23">23</xref>]</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Sexual disoders</th><th align="center" valign="middle" >Our series</th><th align="center" valign="middle" >Jayne et al.</th><th align="center" valign="middle" >Hendren</th><th align="center" valign="middle" >Stamopoulos</th><th align="center" valign="middle" >Bittorf et al. [<xref ref-type="bibr" rid="scirp.100306-ref17">17</xref>]</th></tr></thead><tr><td align="center" valign="middle" >M</td><td align="center" valign="middle" >47.8%</td><td align="center" valign="middle" >50%</td><td align="center" valign="middle" >43%</td><td align="center" valign="middle" >66%</td><td align="center" valign="middle" >69.5%</td></tr><tr><td align="center" valign="middle" >F</td><td align="center" valign="middle" >44.4%</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >39%</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >16.7%</td></tr></tbody></table></table-wrap><p>invasive. It must be proposed only after failure of medical means.</p><p>The therapeutic approach to sexual dysfunction in women, including libido disorders after rectal surgery, is empirically based on sex therapy and psychotherapy [<xref ref-type="bibr" rid="scirp.100306-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.100306-ref16">16</xref>].</p><p>Short-term estrogen therapy is recommended for genital trophicity disorders [<xref ref-type="bibr" rid="scirp.100306-ref17">17</xref>].</p></sec><sec id="s4_2"><title>4.2. Urinary Problems</title><p>Post-operatively, we observed respectively that 2%, 6% and 8% of our patients had urinary problems in the form of acute transient urine retention, urinary incontinence, and urinary burning.</p><p>In the literature, the rate of urinary disorders varies between 30% and 70% [<xref ref-type="bibr" rid="scirp.100306-ref18">18</xref>]. According to Fish, the risk of urinary dysfunction increases with age [<xref ref-type="bibr" rid="scirp.100306-ref9">9</xref>]. Our small numbers do not allow us to compare our results with those of the literature. Two studies have found that urinary disorders are all the more important when the anastomosis is closer to the anus [<xref ref-type="bibr" rid="scirp.100306-ref19">19</xref>] [<xref ref-type="bibr" rid="scirp.100306-ref20">20</xref>]. We have not found this influence of the type of anastomosis.</p><p>There is little consensus on the duration and type of bladder drainage to be implemented after rectal cancer surgery. The recommendations of the French Society of Digestive Surgery underline the interest of the supra pubic catheter in case of tumor of the lower rectum or if a bladder drainage of more than five days is envisaged [<xref ref-type="bibr" rid="scirp.100306-ref21">21</xref>].</p><p>The rate of urinary disorders we have observed is low. At 3 months, this rate is 1%. Del Rio et al., describe 31% of urinary disorders at 3 months [<xref ref-type="bibr" rid="scirp.100306-ref22">22</xref>].</p><p>We do not note any influence of radiotherapy on urinary function contrary to Bonnel and Heriot who report a deleterious effect on this function [<xref ref-type="bibr" rid="scirp.100306-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.100306-ref12">12</xref>].</p><p>The persistence of urinary disorders in our series is 4% to 6 months post-operative, higher than the data in the literature 0 to 2.8% [<xref ref-type="bibr" rid="scirp.100306-ref19">19</xref>].</p><p>We have an overall survival rate at 5 years of 10%, lower than the data in the literature [<xref ref-type="bibr" rid="scirp.100306-ref20">20</xref>]. This could be explained by the fact that the majority of our patients are received in advanced stages and the preoperative radiochemotherapy indicated to reduce the stage often results in difficult, often incomplete R1-type excision, source of recurrence and mortality in the medium term.</p></sec></sec><sec id="s5"><title>5. Conclusion</title><p>The reduction of sexual and urinary complications in the treatment of rectal cancers and their better evaluation and management will only be achieved through wider transdisciplinary consultation. It will also require the accessibility of modern irradiation methods.</p></sec><sec id="s6"><title>Conflicts of Interest</title><p>The authors declare that they have no conflicts of interest in relation to this article.</p></sec><sec id="s7"><title>Cite this paper</title><p>Ba, M.B., Gaye, P.M., Konate, K. and Dem, A. (2020) Sexual and Urinary Disorders after Treatment of Rectal Cancer by Radiotherapy and Surgery at the Dantec University Hospital of Dakar. Journal of Cancer Therapy, 11, 332-338. https://doi.org/10.4236/jct.2020.115027</p></sec></body><back><ref-list><title>References</title><ref id="scirp.100306-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Valentini, V., Aristei, C., Glimelius, B., et al. (2009) Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2). Radiotherapy and Oncology, 92, 148-163.  
https://doi.org/10.1016/j.radonc.2009.06.027</mixed-citation></ref><ref id="scirp.100306-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Boutron Ruault, M.C. and Laurant Puig, P. (2005) Epidemiologie, cancerogenese, facteurs de risqué, prevention et depistage du cancer colo-rectal Traite de gastroenterologie, deuxieme edition. Flammarion, 538-550.</mixed-citation></ref><ref id="scirp.100306-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Benoist, S., Panis, Y., Denet, C., et al. (1999) Optimal Duration of Urinary Drainage after Rectal Resection: A Randomized Controlled Trial. Surgery, 125, 135-141.  
https://doi.org/10.1016/S0039-6060(99)70256-4</mixed-citation></ref><ref id="scirp.100306-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Heald, R.J. (1982) The Mesorectum in Rectal Cancer Surgery: The Clue to Pelvic Recurrence? British Journal of Surgery, 69, 613-616.  
https://doi.org/10.1002/bjs.1800691019</mixed-citation></ref><ref id="scirp.100306-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Mariette, C., Alves, A., Benoist, S., et al. (2005) Perioperative Care in Digestive Surgery: Guidelines for the French Society of Digestive Surgery (SFCD). Annales de Chirurgie, 130, 1847-1824. https://doi.org/10.1016/j.anchir.2004.12.003</mixed-citation></ref><ref id="scirp.100306-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Del Rio, C., Sanchez-Santos, R., Oreja, V., et al. (2004) Long-Term Urinary Dysfunction after Rectal Cancer Surgery. Colorectal Disease, 6, 198-202.  
https://doi.org/10.1111/j.1463-1318.2004.00624.x</mixed-citation></ref><ref id="scirp.100306-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Benani, I. (2017) Traitement radiochirurgical des cancers du rectum à l’institut Joliot curie de Dakar: Etude retrospective de 50 cas. Thèse Médecine, 88.</mixed-citation></ref><ref id="scirp.100306-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Mannaerts, G.H., Schijven, M.P., Hendrikx, A., et al. (2001) Urologic and Sexual Morbidity Following Multimodality Treatment for Locally Advanced Primary and Locally Recurrent Rectal Cancer. European Journal of Surgical Oncology, 27, 108-172. https://doi.org/10.1053/ejso.2000.1099</mixed-citation></ref><ref id="scirp.100306-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Keli, Z. (2013) Profil epidemiologique du cancer colorectal dans la region orientale. These Medicale; Fes; No. 22.</mixed-citation></ref><ref id="scirp.100306-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Basson, R., Althof, S., Davis, S., et al. (2004) Summary of the Recommendations on Sexual Dysfunctions in Women. The Journal of Sexual Medicine, 1, 24-34.  
https://doi.org/10.1111/j.1743-6109.2004.10105.x</mixed-citation></ref><ref id="scirp.100306-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Zippe, C.D., Nandipati, K.C., Agarwal, A., et al. (2005) Female Sexual Dysfunction after Pelvic Surgery: The Impact of Surgical Modifications. BJU International, 96, 959-963. https://doi.org/10.1111/j.1464-410X.2005.05737.x</mixed-citation></ref><ref id="scirp.100306-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Lindsey, I., George, B., Kettlewell, M., et al. (2002) Randomized, Double-Blind, Placebo-Controlled Trial of Sildenafil (Viagra) for Erectile Dysfunction after Rectal Excision for Cancer and Inflammatory Bowel Disease. Diseases of the Colon &amp; Rectum, 45, 727-732. https://doi.org/10.1007/s10350-004-6287-9</mixed-citation></ref><ref id="scirp.100306-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Marijnen, C.A., Van de Velde, C.J., Putter, H., et al. (2005) Impact of Short-Term Preoperative Radiotherapy on Health-Related Quality of Life and Sexual Functioning in Primary Rectal Cancer: Report of a Multicenter Randomized Trial. Journal of Clinical Oncology, 23, 1847-1858. https://doi.org/10.1200/JCO.2005.05.256</mixed-citation></ref><ref id="scirp.100306-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Bonnel, C., Parc, Y.R., Pocard, M., et al. (2002) Effects of Preoperative Radiotherapy for Primary Resectable Rectal Adenocarcinoma on Male Sexual and Urinary Function. Diseases of the Colon &amp; Rectum, 45, 934-939.  
https://doi.org/10.1007/s10350-004-6332-8</mixed-citation></ref><ref id="scirp.100306-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Bregendahl, S., Emmertsen, K.J., Lindegaard, J.C., et al. (2015) Urinary and Sexual Dysfunction in Women after Resection with and without Preoperative Radiotherapy for Rectal Cancer: A Population-Based Cross-Sectional Study. Colorectal Disease, 17, 26-37. https://doi.org/10.1111/codi.12758</mixed-citation></ref><ref id="scirp.100306-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Ho, V.P., Lee, Y., Stein, S.L., et al. (2011) Sexual Function after Treatment for Rectal Cancer: A Review. Diseases of the Colon &amp; Rectum, 54, 113-125.  
https://doi.org/10.1007/DCR.0b013e3181fb7b82</mixed-citation></ref><ref id="scirp.100306-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Larissa, K.F., Douglas, W., Bruce, M., et al. (2003) The Impact of Radiation on Functional Outcomes in Patients with Rectal Cancer and Sphincter Preservation Seminars in Radiation. Oncology, 13, 469-477.  
https://doi.org/10.1016/S1053-4296(03)00051-1</mixed-citation></ref><ref id="scirp.100306-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Canada, A.L., Neese, L.E., Sui, D., et al. (2005) Pilot Intervention to Enhance Sexual Rehabilitation for Couples after Treatment for Localized Prostate Carcinoma. Cancer, 104, 2689-2700. https://doi.org/10.1002/cncr.21537</mixed-citation></ref><ref id="scirp.100306-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Heriot, A.G., Tekkis, P.P., Fazio, V.W., et al. (2005) Adjuvant Radiotherapy Is Associated with Increased Sexual Dysfunction in Male Patients Undergoing Resection for Rectal Cancer: A Predictive Model. Annals of Surgery, 242, 502-510.</mixed-citation></ref><ref id="scirp.100306-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Droupy (2005) Encyclopedie Medico-Chirurgicale. Elsevier, Paris. Urologie.</mixed-citation></ref><ref id="scirp.100306-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Havenga, K., Enker, W.E., Mc Dermott, K., et al. (1996) Male and Female Sexual and Urinary Function after Total Mesorectal Excision with Automatic Nerve Preservation for Carcinoma of Rectum. Journal of the American College of Surgeons, 182, 495-502.</mixed-citation></ref><ref id="scirp.100306-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">https://orbi.ulg.ac.be/bitstream/2268/164040/1/LA%20RADIOTH%C3%89RAPIE%20DANS%20LE%20CANCER%20DU%20RECTUM.pdf</mixed-citation></ref><ref id="scirp.100306-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Beets-Tan, R.G., Beets, G.L., Vliegen, R.F., et al. (2001) Accuracy of Magnetic Resonance Imaging in Prediction of Tumor-Free Resection Margin in Rectal Cancer Surgery. The Lancet, 357, 497-504. https://doi.org/10.1016/S0140-6736(00)04040-X</mixed-citation></ref></ref-list></back></article>